[go: up one dir, main page]

AU2001234992A1 - Methods for generating hypermutable bacteria - Google Patents

Methods for generating hypermutable bacteria

Info

Publication number
AU2001234992A1
AU2001234992A1 AU2001234992A AU3499201A AU2001234992A1 AU 2001234992 A1 AU2001234992 A1 AU 2001234992A1 AU 2001234992 A AU2001234992 A AU 2001234992A AU 3499201 A AU3499201 A AU 3499201A AU 2001234992 A1 AU2001234992 A1 AU 2001234992A1
Authority
AU
Australia
Prior art keywords
bacteria
methods
mismatch repair
generating hypermutable
desirable output
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001234992A
Other languages
English (en)
Inventor
Luigi Grasso
Kenneth W. Kinzler
Nicholas C. Nicolaides
Philip M. Sass
Bert Vogelstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of AU2001234992A1 publication Critical patent/AU2001234992A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • C12N15/1024In vivo mutagenesis using high mutation rate "mutator" host strains by inserting genetic material, e.g. encoding an error prone polymerase, disrupting a gene for mismatch repair
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001234992A 2000-02-11 2001-02-12 Methods for generating hypermutable bacteria Abandoned AU2001234992A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18192900P 2000-02-11 2000-02-11
US60/181,929 2000-02-11
PCT/US2001/004339 WO2001059092A2 (fr) 2000-02-11 2001-02-12 Procedes d'obtention de microbes hypermutables

Publications (1)

Publication Number Publication Date
AU2001234992A1 true AU2001234992A1 (en) 2001-08-20

Family

ID=22666395

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001234992A Abandoned AU2001234992A1 (en) 2000-02-11 2001-02-12 Methods for generating hypermutable bacteria

Country Status (7)

Country Link
US (3) US7026119B2 (fr)
EP (1) EP1268765B1 (fr)
AT (1) ATE404665T1 (fr)
AU (1) AU2001234992A1 (fr)
CA (1) CA2398094C (fr)
DE (1) DE60135312D1 (fr)
WO (1) WO2001059092A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365410B1 (en) * 1999-05-19 2002-04-02 Genencor International, Inc. Directed evolution of microorganisms
ATE404665T1 (de) * 2000-02-11 2008-08-15 Univ Johns Hopkins Methode zur herstellung hypermutierender bakterien
WO2001088192A2 (fr) 2000-05-12 2001-11-22 The Johns Hopkins University Procede de generation d'organismes a mutabilite tres elevee
US6737268B1 (en) * 2000-11-14 2004-05-18 Morphotek, Inc. Method for generating genetically altered antigens
ATE548461T1 (de) 2002-01-18 2012-03-15 Morphotek Inc Verfahren zur erzeugung manipulierter zellen zur locus-spezifischen genregulation und analyse
EP2110440B1 (fr) * 2002-02-21 2010-12-22 Morphotek, Inc. Vecteurs régulés pour contrôler l'hypermutabilité de l'ADN dans des cellules eucaryotiques
AU2003248361B2 (en) * 2002-02-21 2008-07-03 Morphotek, Inc. Methods of making hypermutable cells using PMSR homologs
CA2506127C (fr) 2002-11-15 2013-07-09 Morphotek, Inc. Methodes de generation d'une quantite elevee d'anticorps a partir d'hybridomes crees par immunisation in vitro
WO2006032504A2 (fr) * 2004-09-22 2006-03-30 Vrije Universiteit Brussel Procede permettant d'introduire des mutations genetiques dans des cellules vegetales
US20090068741A1 (en) * 2007-01-17 2009-03-12 Invitrogen Corporation Methods and Compositions for Improving the Health of Cells in Culture
JP5537420B2 (ja) 2007-05-31 2014-07-02 ユニヴァーシティ オブ ワシントン 標的遺伝子の誘導性変異誘発
CN102911962B (zh) * 2011-08-02 2017-03-22 中国科学院微生物研究所 改造微生物获得改进表型的方法
AU2013232114B2 (en) 2012-03-15 2018-10-18 Omeros Corporation Composition and method for diversification of target sequences
US20190119667A1 (en) * 2017-09-16 2019-04-25 Massachusetts Institute Of Technology Methods for Directed Exaptation
CN108753814B (zh) * 2018-06-11 2022-10-18 北京师范大学 一种加速物种突变的新育种方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191268B1 (en) 1993-12-17 2001-02-20 Dana-Farber Cancer Institute Compositions and methods relating to DNA mismatch repair genes
US5843757A (en) 1995-08-24 1998-12-01 The Johns Hopkins University Human JTV1 gene overlaps PMS2 gene
US5907079A (en) 1996-01-18 1999-05-25 Amgen Canada Inc. MSH2 disrupted mice develop lymphomas
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
AUPO974597A0 (en) 1997-10-10 1997-11-06 Rhone-Poulenc Agro Methods for obtaining plant varieties
US6146894A (en) 1998-04-14 2000-11-14 The Johns Hopkins University Method for generating hypermutable organisms
ATE404665T1 (de) * 2000-02-11 2008-08-15 Univ Johns Hopkins Methode zur herstellung hypermutierender bakterien
DK1259628T5 (da) * 2000-02-23 2018-06-14 Univ Johns Hopkins Fremgangsmåde til dannelse af hypermutabel gær
US6737268B1 (en) * 2000-11-14 2004-05-18 Morphotek, Inc. Method for generating genetically altered antigens

Also Published As

Publication number Publication date
WO2001059092A9 (fr) 2002-10-24
WO2001059092A2 (fr) 2001-08-16
CA2398094A1 (fr) 2001-08-16
DE60135312D1 (de) 2008-09-25
EP1268765B1 (fr) 2008-08-13
US7892832B2 (en) 2011-02-22
US20060194236A1 (en) 2006-08-31
EP1268765A2 (fr) 2003-01-02
CA2398094C (fr) 2013-01-08
US20080318321A1 (en) 2008-12-25
WO2001059092A3 (fr) 2002-07-25
US7695969B2 (en) 2010-04-13
US20020068284A1 (en) 2002-06-06
ATE404665T1 (de) 2008-08-15
US7026119B2 (en) 2006-04-11

Similar Documents

Publication Publication Date Title
AU2001234992A1 (en) Methods for generating hypermutable bacteria
MXPA03011329A (es) Antiinfecciosos novedosos.
MY120511A (en) New pesticides
MXPA05002535A (es) Sistema de riel.
FR15C0055I1 (fr)
AU2003205712A1 (en) Phenylalanine derivatives as herbicides
JO2305B1 (en) Gels extracted from wood
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
CA2264066A1 (fr) Composes antiparasitaires isoles de la fermentation du nodulisporium sp
NO975557D0 (no) Immortalisering og dismortalisering av celler
AU1878197A (en) Agents and processes for the production of aquarial and garden pond water
WO2004052313A3 (fr) Agents antiinfectieux
WO2004058150A3 (fr) Anti-infectieux
JO2369B1 (en) New cyclohexyl sulfonate
MXPA02010907A (es) Decorina producida transgenicamente.
TR199901386T2 (en) �midazopiridazinler.
GB9807114D0 (en) Novel process
MXPA02011558A (es) Inhibidores de mmp-2/mp-9 novedosos.
AU2003241196A1 (en) Microorganism for producing riboflavin and method for producing riboflavin using the same
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
AU2002230579A1 (en) Calcilytic compounds
ATE376586T1 (de) Ppgpp-synthetase und expressionssysteme zur verbesserten herstellung von proteinen
MY128306A (en) Oct formulations
DE69531627D1 (de) Humane hypertrophe chrondrozyten zelllinien
AU2002216102A1 (en) Method for producing biomass